Skip to main content
Log in

Predictive factors for long-term survival in head and neck squamous cell carcinoma patients with distant metastasis after initial definitive treatment

  • Original Article – Clinical Oncology
  • Published:
Journal of Cancer Research and Clinical Oncology Aims and scope Submit manuscript

Abstract

Purpose

Distant metastasis (DM) of head and neck squamous cell carcinoma (HNSCC) is not common but remains a substantial problem. Here, we evaluated factors predictive of long-term survival in HNSCC patients presenting with DM after initial definitive treatment.

Methods

The medical records of patients with HNSCC who underwent definitive treatment between 2006 and 2011 were reviewed. Univariate and multivariate analyses were performed to identify clinicopathological factors associated with long-term survival after DM.

Results

Of 779 HNSCC patients, 98 (12.6 %) had DM after completion of definitive treatment, with a median time to DM of 15 months (range 1–87 months). Overall survival (OS) rates at 1 and 2 years after DM were 43.1 and 20.5 %, respectively. In multivariate analysis, hypoalbuminemia (P < 0.001, hazard ratio [HR] 3.45, 95 % confidence interval [CI] 2.01–5.92), prior or simultaneous locoregional failure events (P < 0.001, HR 2.36, 95 % CI 1.47–3.79), multisite DM (P = 0.001, HR 2.30, 95 % CI 1.42–3.72), and no salvage treatment for DM (P = 0.003, HR 2.19, 95 % CI 1.32–3.64) were independent predictors of OS after the development of DM. Seventeen (18 %) patients survived >2 years. Patients who did not have any of these risk factors had the most favorable outcomes, with a 2-year survival of 100 %.

Conclusions

In the absence of risk factors, long-term survival can be achieved despite the development of DM after definitive treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  • Adelstein DJ, Leblanc M (2006) Does induction chemotherapy have a role in the management of locoregionally advanced squamous cell head and neck cancer? J Clin Oncol 24:2624–2628

    Article  PubMed  Google Scholar 

  • Ang KK et al (2001) Randomized trial addressing risk features and time factors of surgery plus radiotherapy in advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys 51:571–578

    Article  PubMed  CAS  Google Scholar 

  • Argiris A, Karamouzis MV, Raben D, Ferris RL (2008) Head and neck cancer. Lancet 371:1695–1709

    Article  PubMed  CAS  Google Scholar 

  • Charlson ME, Pompei P, Ales KL, Mackenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chr Dis 40:373–383

    Article  CAS  Google Scholar 

  • Chen TC et al (2013) The clinical predictive factors for subsequent distant metastasis in patients with locoregionally advanced oral squamous cell carcinoma. Oral Oncol 49(4):367–373

    Article  PubMed  Google Scholar 

  • Dragovic AF, Caudell JJ, Spencer SA, Carroll WR, Nabell LA, Bonner JA (2013) Locoregional failure and the risk of distant metastasis after modern radiotherapy for head and neck cancer. Head Neck 35:381–387

    Article  PubMed  Google Scholar 

  • Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A (2010) AJCC Cancer Staging Manual, 7th edn. NY, Springer, New York, pp 21–78

    Google Scholar 

  • Haddad RI, Shin DM (2008) Recent advances in head and neck cancer. N Engl J Med 359:1143–1154

    Article  PubMed  CAS  Google Scholar 

  • Hellman S (1994) Karnofsky Memorial Lecture. Natural history of small breast cancers. J Clin Oncol 12:2229–2234

    PubMed  CAS  Google Scholar 

  • Huang SH et al (2013) Natural course of distant metastases following radiotherapy or chemoradiotherapy in HPV-related oropharyngeal cancer. Oral Oncol 49:79–85

    Article  PubMed  Google Scholar 

  • Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61:69–90

    Article  PubMed  Google Scholar 

  • Kim JW et al (2013) (18)F-FDG PET/CT surveillance at 3-6 and 12 months for detection of recurrence and second primary cancer in patients with head and neck squamous cell carcinoma. Br J Cancer 109:2973–2979

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  • Kramer S, Marcial VA, Pajak TF, MacLean CJ, Davis LW (1986) Prognostic factors for loco/regional control and metastasis and the impact on survival. Int J Radiat Oncol Biol Phys 12:573–578

    Article  PubMed  CAS  Google Scholar 

  • Leon X, Quer M, Orus C, Del Prado Venegas M, Lopez M (2000) Distant metastases in head and neck cancer patients who achieved loco-regional control. Head Neck 22:680–686

    Article  PubMed  CAS  Google Scholar 

  • Liao CT et al (2007) Analysis of risk factors for distant metastases in squamous cell carcinoma of the oral cavity. Cancer 110:1501–1508

    Article  PubMed  Google Scholar 

  • McBride SM, Busse PM, Clark JR, Wirth LJ, Ancukiewicz M, Chan AW (2014) Long-term survival after distant metastasis in patients with oropharyngeal cancer. Oral Oncol 50:208–212

    Article  PubMed  Google Scholar 

  • Shiono S et al (2009) Pulmonary metastasectomy for pulmonary metastases of head and neck squamous cell carcinomas. Ann Thorac Surg 88:856–860

    Article  PubMed  Google Scholar 

  • Siegel R, Ma J, Zou Z, Jemal A (2014) Cancer statistics, 2014. CA Cancer J Clin 64:9–29

    Article  PubMed  Google Scholar 

  • Vermorken JB et al (2008) Platinum-based chemotherapy plus cetuximab in head and neck cancer. N Engl J Med 359:1116–1127

    Article  PubMed  CAS  Google Scholar 

  • Wedman J et al (1996) Value of resection of pulmonary metastases in head and neck cancer patients. Head Neck 18:311–316

    Article  PubMed  CAS  Google Scholar 

  • Winter H et al (2008) Does surgical resection of pulmonary metastases of head and neck cancer improve survival? Ann Surg Oncol 15:2915–2926

    Article  PubMed  Google Scholar 

  • Xu GZ, Guan DJ, He ZY (2011) (18)FDG-PET/CT for detecting distant metastases and second primary cancers in patients with head and neck cancer. A meta-analysis. Oral Oncol 47:560–565

    Article  PubMed  Google Scholar 

  • Yao M et al (2012) Distant metastases in head-and-neck squamous cell carcinoma treated with intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys 83:684–689

    Article  PubMed  Google Scholar 

  • Yi JS et al (2012) 18F-FDG PET/CT for detecting distant metastases in patients with recurrent head and neck squamous cell carcinoma. J Surg Oncol 106:708–712

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

This study was supported by a Grant (No. 2014-0306) from the Asan Institute for Life Science and a Grant (HI14C23050000) from the Korean Health Technology R&D Project, Ministry of Health and Welfare, Seoul, Republic of Korea (J.-L. Roh).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jong-Lyel Roh.

Ethics declarations

Conflict of interest

The authors have no conflict of interests to disclose.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOC 173 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kang, HS., Roh, JL., Kim, MJ. et al. Predictive factors for long-term survival in head and neck squamous cell carcinoma patients with distant metastasis after initial definitive treatment. J Cancer Res Clin Oncol 142, 295–304 (2016). https://doi.org/10.1007/s00432-015-2043-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00432-015-2043-x

Keywords

Navigation